<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(4)</volume><submitter>Saravolatz LD</submitter><funding>Thomas Mackey Center for Infectious Disease Research</funding><funding>Ascension St John Hospital Department of Medicine</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Rhodomyrtone is a novel plant-derived antibiotic compound originally isolated from &lt;i>Rhodomyrtus tomentosa&lt;/i> leaf extract.&lt;h4>Objectives&lt;/h4>To evaluate the activity of rhodomyrtone against a group of MRSA strains, including isolates with reduced susceptibility or resistance to vancomycin, daptomycin, linezolid and ceftaroline.&lt;h4>Methods&lt;/h4>Broth microdilution testing was used to determine the MICs and MBCs of rhodomyrtone, fosfomycin, vancomycin, daptomycin, linezolid and ceftaroline.&lt;h4>Results&lt;/h4>ROM had an MIC&lt;sub>90&lt;/sub> of 1 mg/L against 110 strains of MRSA from blood isolates as well as for all other isolates that were daptomycin resistant, VISA, VRSA or LRSA. The MBC&lt;sub>90&lt;/sub> were 4 mg/L across all groups tested. Among all &lt;i>S. aureus&lt;/i> groups teste</pubmed_abstract><journal>JAC-antimicrobial resistance</journal><pagination>dlae097</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11220652</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Rhodomyrtone: a new anti-&lt;i>Staphylococcus aureus&lt;/i> agent against resistant strains.</pubmed_title><pmcid>PMC11220652</pmcid><pubmed_authors>Pawlak J</pubmed_authors><pubmed_authors>Saravolatz LD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Rhodomyrtone: a new anti-&lt;i>Staphylococcus aureus&lt;/i> agent against resistant strains.</name><description>&lt;h4>Background&lt;/h4>Rhodomyrtone is a novel plant-derived antibiotic compound originally isolated from &lt;i>Rhodomyrtus tomentosa&lt;/i> leaf extract.&lt;h4>Objectives&lt;/h4>To evaluate the activity of rhodomyrtone against a group of MRSA strains, including isolates with reduced susceptibility or resistance to vancomycin, daptomycin, linezolid and ceftaroline.&lt;h4>Methods&lt;/h4>Broth microdilution testing was used to determine the MICs and MBCs of rhodomyrtone, fosfomycin, vancomycin, daptomycin, linezolid and ceftaroline.&lt;h4>Results&lt;/h4>ROM had an MIC&lt;sub>90&lt;/sub> of 1 mg/L against 110 strains of MRSA from blood isolates as well as for all other isolates that were daptomycin resistant, VISA, VRSA or LRSA. The MBC&lt;sub>90&lt;/sub> were 4 mg/L across all groups tested. Among all &lt;i>S. aureus&lt;/i> groups teste</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-01T20:34:55.196Z</modification><creation>2025-04-06T00:12:32.589Z</creation></dates><accession>S-EPMC11220652</accession><cross_references><pubmed>38966334</pubmed><doi>10.1093/jacamr/dlae097</doi></cross_references></HashMap>